WHX Labs Dubai is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Informa

WHX Labs Dubai

AMR Leaders’ Summit

Theme: Policy. Technology. Solutions. Tackling AMR Leaders’ Summit

12–13 February 2026

The AMR Summit is a flagship launch within WHX Labs Dubai 2026, spotlighting the global health threat of antimicrobial resistance (AMR). Designed to convene a multidisciplinary alliance of scientists, clinicians, policymakers, and innovators, the summit bridges the gap between research and implementation. The program will feature pioneering diagnostics, policy frameworks, and technology-driven solutions, empowering attendees to drive real-world impact. From global surveillance to sustainable innovation, this summit places AMR at the forefront of healthcare transformation in the region and beyond.
  • Implementing national AMR action plans: gaps and opportunities in the region
  • Surveillance systems and genomics in AMR tracking
  • Diagnostics as a frontline defense: rapid testing and POCT integration
  • Antibiotic stewardship models in hospital and community settings
  • One Health approach: environmental and veterinary intersections
  • Policy innovations and funding models for sustainable AMR combat
  • Technology transfer and local manufacturing for AMR solutions
  • Patient safety, infection control, and AMR outcomes
  • First GCC-based AMR launch inside a global-scale diagnostics platform ensuring both technical depth and policy reach.
  • Bridges policy, technology, and clinical implementation not siloed in science-only or policy-only spaces.
  • Global + Regional focus: Content shaped by international AMR leaders but grounded in GCC and MENA realities.
  • Embedded in WHX Labs’ scale-20,000+ attendees across tracks; AMR Summit leverages this visibility while maintaining its own identity.
  • Outcome-driven: Aims for policy commitments, funding pledges, and cross-sector partnerships, not just presentations.
WHX Labs Dubai
Attendee profile
Clinical Specialists

  • Infectious Disease Physicians
  • Clinical Microbiologists
  • AMR Diagnostics Specialists
Research & Academia

  • Principal Investigators in AMR research
  • Microbiology Researchers
  • Epidemiologists studying resistance patterns
  • Translational Research Leaders
Industry & Innovation

  • Executives in Pharmaceutical Development
  • Founders and CEOs of Biotech Companies
  • Innovators in Diagnostic Platforms
  • Investors in Health Technology
Policy & Implementation

  • Directors of Regulatory Affairs
  • Healthcare Policy Advisors focused on AMR
  • Members of Ethics Committees addressing AMR challenges
  • Leaders in Patient Advocacy
Leadership & Executive

  • Chief Medical Officers (CMOs)
  • Chief Scientific Officers (CSOs)
  • Directors of Research & Development (R&D)
  • CEOs of Hospitals and Health Systems
  • Programme Directors for AMR initiatives
Scientific chairs
Chair
Chair
Dr. Wael Elamin

Medical Director, Environmental Sciences, M42

Co-chair
Co-chair
Prof. Abiola Senok

Chair of Basic Medical Sciences and Professor, Microbiology and Infectious Diseases, MBRU

Co-chair
Co-chair
Dr. Kavita Diddi

President, Emirates Society of Clinical Microbiology (ESCM)

Co-chair
Co-chair
Dr Seema Oommen

Section Head, Microbiology and Infectious Molecular, Burjeel Medical city | coLAB, Burjeel Holdings

Tackling AMR together
Join the movement, innovation & solution against AMR